Vanda Pharmaceuticals (VNDA) Other Operating Expenses (2010 - 2026)

Vanda Pharmaceuticals' Other Operating Expenses history runs 17 years deep, the most recent figure standing at $4.9 million for Q1 2026.

• In Q1 2026, Other Operating Expenses fell 3.35% year-over-year to $4.9 million; the TTM figure through Mar 2026 stood at $113.6 million (up 550.28% YoY), while the FY2025 annual figure was $113.8 million, up 543.52% from the prior year.
• Other Operating Expenses came in at $4.9 million for Q1 2026 at Vanda Pharmaceuticals, down from $100.2 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $100.2 million in Q4 2025 to a low of $3.2 million in Q3 2023.
• A 5-year average of $10.4 million and a median of $4.9 million in 2023 frame the typical range for Other Operating Expenses.
• Across the five-year window, Other Operating Expenses sank 49.33% in 2023 and soared 2354.71% in 2025, its largest moves.
• Vanda Pharmaceuticals' Other Operating Expenses stood at $6.4 million in 2022, then plunged by 33.73% to $4.2 million in 2023, then retreated by 3.04% to $4.1 million in 2024, then jumped by 2354.71% to $100.2 million in 2025, then slumped by 95.13% to $4.9 million in 2026.
• According to Business Quant data, Other Operating Expenses over the past three periods registered $4.9 million, $100.2 million, and $4.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison